Product image of Methylphenidat Stada (Methylphenidate Hydrochloride) supplied by GNH India

Methylphenidat Stada

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Methylphenidat Stada (Methylphenidate Hydrochloride)

Methylphenidate Hydrochloride, the active ingredient in Methylphenidat Stada, is a central nervous system stimulant presented as an oral formulation for oral use. It is indicated for the treatment of attention deficit hyperactivity disorder and narcolepsy in children, adolescents, and adults. By inhibiting the reuptake of dopamine and norepinephrine, it raises their synaptic concentrations, which helps improve focus and reduce excessive daytime sleepiness.

GNH India supplies Methylphenidat Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality, regulatory compliance, and reliable logistics for global distribution.

Manufacturer / TM Owner

Stada Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylphenidate Hydrochloride is a central nervous system stimulant used in the management of neurobehavioral disorders.

  • Attention deficit hyperactivity disorder (ADHD): improves attention, reduces hyperactivity and impulsivity in children, adolescents, and adults.
  • Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness.
  • ADHD in adults: enhances occupational performance and daily functioning.
  • ADHD in children: supports academic performance and behavior control.

How It Works

  • Methylphenidate Hydrochloride blocks the dopamine transporter (DAT) and norepinephrine transporter (NET), inhibiting reuptake of these catecholamines into presynaptic neurons. The resulting increase in extracellular dopamine and norepinephrine enhances neurotransmission in cortical and subcortical pathways that regulate attention, impulse control, and arousal. This pharmacologic action underlies its therapeutic effect in ADHD and narcolepsy. The heightened catecholamine activity particularly affects the prefrontal cortex, which is critical for executive functions.

Side Effects

Methylphenidate Hydrochloride may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Insomnia: difficulty falling or staying asleep.
  • Decreased appetite: reduced hunger leading to weight loss.
  • Headache: mild to moderate cranial pain.
  • Irritability: increased mood swings or agitation.

Serious or Rare Side Effects

  • Cardiovascular events: chest pain, hypertension, or arrhythmia.
  • Psychosis or severe agitation: hallucinations or extreme behavioral changes.
  • Allergic reactions: rash, swelling, or anaphylaxis.

Precautions & Warnings

When prescribing Methylphenidate Hydrochloride, clinicians should consider several safety precautions.

  • Cardiovascular assessment: evaluate heart disease history and blood pressure before initiation.
  • Psychiatric monitoring: observe for mood swings, anxiety, or emergence of psychotic symptoms.
  • Growth monitoring: regularly track height and weight in pediatric patients.
  • Abuse potential: use only as directed due to risk of dependence.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Methylphenidate Hydrochloride can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • MAO inhibitors: concurrent use may cause hypertensive crisis.
  • Antihypertensive agents: may reduce blood pressure control.
  • Antipsychotics: can diminish stimulant effect and increase side effects.

Moderate Interactions (Monitor Closely)

  • SSRIs and SNRIs: may increase risk of serotonin syndrome.
  • CYP2D6 inhibitors: can raise methylphenidate plasma levels.

Frequently Asked Questions

Methylphenidat Stada contains methylphenidate hydrochloride and is prescribed for attention deficit hyperactivity disorder (ADHD) and for narcolepsy. In both indications the medication helps improve focus, reduce impulsivity, and lessen excessive daytime sleepiness.

Methylphenidate hydrochloride blocks the reuptake transporters for dopamine and norepinephrine, increasing the concentration of these neurotransmitters in the synaptic cleft. The enhanced signaling in cortical and subcortical pathways improves attention, executive function, and wakefulness.

The appropriate dose of Methylphenidat Stada is determined by the prescribing clinician based on the patient’s age, weight, clinical response, and tolerability. Dosage adjustments are made individually and should follow local prescribing guidelines.

Safety of methylphenidate during pregnancy or lactation has not been fully established. Healthcare providers usually weigh potential benefits against possible risks and may recommend alternative therapies when possible. Patients should discuss any concerns with their prescriber.

To request Methylphenidat Stada, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methylphenidate is a first‑line stimulant for ADHD and is often compared with amphetamine‑based products. Both classes increase dopamine and norepinephrine activity, but methylphenidate generally has a shorter half‑life and may have a different side‑effect profile. Choice of therapy depends on individual response, tolerability, and prescriber preference.

Methylphenidat Stada should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and out of reach of children.

The medication is taken orally, usually in tablet or capsule form, as directed by the prescriber. It may be taken with or without food, and the dosing schedule (once or multiple times daily) is individualized.

Serious risks include cardiovascular events such as hypertension or arrhythmia, severe psychiatric reactions like psychosis or mania, and rare allergic reactions that can be life‑threatening. Patients should be monitored regularly for any concerning symptoms.

Methylphenidat Stada is contraindicated in individuals with known hypersensitivity to methylphenidate, those taking monoamine oxidase inhibitors, and patients with certain cardiovascular conditions, severe anxiety, or a history of substance misuse. A prescriber should evaluate each patient’s medical history before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT